secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001193125-24-003887
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences updates corporate presentation for J.P. Morgan Healthcare Conference
--------------------------------------------------------------------------------

- Company conducting investor meetings at 42nd Annual J.P. Morgan Healthcare Conference starting January 8, 2024.
- Updated corporate presentation furnished as Exhibit 99.1; no specific financial or pipeline updates disclosed in the filing.
- Presentation contains forward-looking statements; risks detailed in prior SEC filings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000119312524003887/0001193125-24-003887-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000119312524003887/d740672d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-003887

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer